Drug Shortages and Otolaryngology

Author:

Esce Antoinette R.1ORCID,Shuman Andrew G.23

Affiliation:

1. Department of Surgery, Division of Otolaryngology–Head and Neck Surgery University of New Mexico Health Sciences Center Albuquerque New Mexico USA

2. Department of Otolaryngology–Head and Neck Surgery University of Michigan Medical School Ann Arbor Michigan USA

3. Center for Bioethics and Social Sciences in Medicine University of Michigan Medical School Ann Arbor Michigan USA

Abstract

AbstractEvery year in the United States, hundreds of shortages of life‐saving, essential drugs impact patients and health care workers. While otolaryngologists may be shielded from these relative to other specialties, there is still a significant clinical impact with potentially dangerous consequences. Shortages of local anesthetics lead to increased costs, labor demands, and risk of medical errors. Shortages of cisplatin and carboplatin, workhorses in head and neck oncology, may leave patients without proven alternative therapies. The economic and geopolitical challenges that provoke these shortages are well described. So too are potential solutions at the national, regional, and local levels. Otolaryngologists have a responsibility to contribute to coordinated responses to drug shortages to protect and advocate for their current and future patients.

Publisher

Wiley

Subject

Otorhinolaryngology,Surgery

Reference11 articles.

1. Drug change: ‘a hassle like no other’. An in-depth investigation using the Danish patient safety database and focus group interviews with Danish hospital personnel

2. NoguchiY.Some cancer drugs are in short supply putting patients' care at risk. Here's why. June 15 2023. Accessed July 17 2023.https://www.npr.org/sections/health-shots/2023/06/15/1181876655/cancer-drugs-cisplatin-carboplatin-shortage

3. Committee on Homeland Security & Governmental Affairs.Peters Stabenow & Slotkin call on FDA to take all possible actions to mitigate cancer drug shortages. May 25 2023. Accessed July 17 2023.https://www.hsgac.senate.gov/media/dems/peters-stabenow-slotkin-call-on-fda-to-take-all-possible-actions-to-mitigate-cancer-drug-shortages/

4. American Society of Health‐System Pharmacists.Drug Shortages List. 2023. Accessed July 17 2023.https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List

5. US Food and Drug Administration. The Drug Shortages Task Force.Drug shortages: root causes and potential solutions. 2019. Accessed July 12 2023.https://www.fda.gov/media/131130/download

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3